Demo Sign up Log In

Spyre Therapeutics Inc (SYRE)

Cash Conversion Ratio

0.71×

Quarterly · Period ending: Dec 31, 2025

SYRE Cash Conversion Ratio

Latest reported0.71×period endingDec 31, 2025

Latest reported0.71×period endingDec 31, 2025

SYRE Quarterly Cash Conversion Ratio (2.72× → 0.71×)

Latest values, visible window

High-resolution chart · PNG

SYRE cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Dec 31, 2025	0.7129×
Jun 30, 2023	0.0767×
Mar 31, 2023	0.9572×
Dec 31, 2022	0.9638×
Sep 30, 2022	0.8264×
Jun 30, 2022	0.9261×
Mar 31, 2022	1.0763×
Dec 31, 2021	0.9424×
Sep 30, 2021	0.8417×
Jun 30, 2021	-0.3004×
Jun 30, 2018	0.9644×
Mar 31, 2018	0.9275×
Dec 31, 2017	0.9354×
Sep 30, 2017	0.9498×
Jun 30, 2017	0.9029×
Mar 31, 2017	0.9129×
Dec 31, 2016	0.8163×
Sep 30, 2016	0.9402×
Jun 30, 2016	0.8694×
Mar 31, 2016	0.8775×
Dec 31, 2015	0.219×
Sep 30, 2015	1.1559×
Jun 30, 2015	2.7183×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.